Dementia with Lewy bodies and Alzheimer's disease

Acta Neuropathologica

Volumn 102, Issue 6, 2001, Pages 621-626

  Rosenberg, Carlyn K ^a   Cummings, Thomas J ^a   Saunders, Ann M ^a   Widico, Corinne ^a   McIntyre, Lauren M ^a   Hulette, Christine M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia with Lewy bodies

Indexed keywords

APOLIPOPROTEIN E;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN INFARCTION; BRAIN TUMOR; BRAIN WEIGHT; CONTROLLED STUDY; DEATH; DEGENERATIVE DISEASE; DEMENTIA; DEMOGRAPHY; DISEASE DURATION; FEMALE; GENDER; GENOTYPE; HEALTH CARE FACILITY; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; STAGING; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0035157560     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010100415     Document Type: Article

References (49)

1. Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease
2. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's Disease
3. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients
4. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older
5. Lewy bodies in Alzheimer disease: One or two diseases?
6. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease
7. Neuropathological stageing of Alzheimer-related changes
8. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: A comparison with classic Alzheimer disease and normal aging
9. Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies
10. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
11. Lewy body variant of Alzheimer's disease
12. Diffuse Lewy body disease: Light and electron microscopic immunocytochemistry of senile plaques
13. Clinical-neuropathological correlations in Alzheimer's disease and related dementias
14. The apolipoprotein E allele epsilon4 is over-represented in patients with the Lewy body variant of Alzheimer's disease
15. Alzheimer's disease with concomitant Parkinson's disease changes: Two subgroups defined by neurofibrillary pathology
16. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia)
17. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons
18. Dementia in Parkinson's disease: A neuropathologic study
19. Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using α-synuclein immunohistochemistry
20. Lewy body disease
21. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change
22. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease
23. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases
24. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease
25. Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience
26. Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute working group on diagnostic criteria for the neuropathological Alzheimer disease
27. Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases
28. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases
29. Pathology of senile brains
30. Diffuse Lewy body disease in Japan
31. The clinicopathologic spectrum of Lewy body disease
32. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease
33. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
34. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease
35. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists
36. The effects of additional pathology on the cognitive deficit in Alzheimer's disease
37. The apolipoprotein E epsilon4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant
38. Pathology and biology of the body
39. Hypothalamic-pituitary-adrenal dysfunction in Apoe-/-mice: Possible role in behavioral and metabolic alterations
40. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra
41. Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation
42. Neuropsychological deficits associated with diffuse Lewy body disease
43. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease
44. Association of apolipoprotein E allele epsilon4 with late-onset familial and sporadic Alzheimer's disease
45. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
46. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: Potential genetic and phenotypic heterogeneity
47. Apolipoprotein E: High avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
48. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly
49. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia